SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017
Search This Board:
Last Post: 1/21/2017 11:15:11 AM - Followers: 117 - Board type: Free - Posts Today: 0


Pluristem Therapeutics Inc. (Nasdaq: PSTI)




Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172
E-Mail: [email protected]


CIK:  0001158780


Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 



Clinical Program:

Recent News and Press:






Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501


Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America
[email protected]




All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
PSTI News: Current Report Filing (8-k) 01/20/2017 04:34:38 PM
PSTI News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 01/20/2017 07:01:23 AM
PSTI News: Pluristem Increases Previously Announced Bought Deal Offering of Common Stock and Warrants to $15,000,000 01/20/2017 07:00:00 AM
PSTI News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 01/19/2017 05:13:50 PM
PSTI News: Pluristem Announces Bought Deal Offering 01/19/2017 04:53:20 PM
#4130   PPHM has its own Avid subsidiary with large north40000 01/21/17 11:15:11 AM
#4129   That was my buying range for adding 10k north40000 01/21/17 11:08:36 AM
#4128   Maxim Group Reiterates “$3.00” Price Target for Pluristem midastouch017 01/21/17 07:25:43 AM
#4127   * * $PSTI Video Chart 01-20-17 * * ClayTrader 01/20/17 04:26:48 PM
#4126   for a buck a share you can't go thesaud 01/20/17 02:41:16 PM
#4125   Nice. I'm not in that league and sekander 01/20/17 11:42:05 AM
#4124   I'm in. Hello, longs. I realize sekander 01/20/17 11:31:23 AM
#4123   I added another 25,000 this am at 1.04. thesaud 01/20/17 11:29:13 AM
#4122   sekander 01/20/17 10:29:30 AM
#4121   Hey Saud, did you get in? This sekander 01/20/17 10:29:26 AM
#4120   From the Yahoo MB midastouch017 01/20/17 10:10:51 AM
#4119   pre market volume over a mil trading 1.00 Traderdave1266 01/20/17 09:22:03 AM
#4118   Oy-Vey, Oy-Vey, an average midastouch017 01/20/17 08:46:12 AM
#4117   over a half a million shares traded already thesaud 01/20/17 08:27:41 AM
#4116   Pluristem increases underwriting deal with Wainwright to $15M; midastouch017 01/20/17 07:53:24 AM
#4115   Pluristem Announces Bought Deal Offering midastouch017 01/20/17 04:23:00 AM
#4114   This company is totally under the radar with Melon4head 01/19/17 02:54:05 PM
#4113   One question....why is there only a little more andypro 01/19/17 02:14:29 PM
#4112   Changing of the "Guard" Folks... In preparation of Melon4head 01/19/17 01:14:06 PM
#4111   Flood of News Presents Buying Opportunity midastouch017 01/17/17 02:44:31 PM
#4110   Pluristem on go in Germany to start late-stage midastouch017 01/17/17 07:29:08 AM
#4109   Pluristem Receives Clearance from Germany to Initiate its midastouch017 01/17/17 06:14:07 AM
#4108   I wouldn't get overly midastouch017 01/13/17 08:44:56 AM
#4107   up 14 cents in pm I think we thesaud 01/13/17 08:10:08 AM
#4106   Pluristem Completes Patient Enrollment in a Large Multinational midastouch017 01/12/17 09:06:06 AM
#4105   Pluristem’s Phase III Study of PLX-PAD Cells for midastouch017 01/10/17 07:47:54 AM
#4104   its all shaping up nice for a breakout thesaud 12/27/16 08:46:59 AM
#4103   Pluristem and New York Blood Center to Collaborate midastouch017 12/27/16 06:01:28 AM
#4102   Pluristem and Innovative Medical Management Co., Ltd. Mutually midastouch017 12/23/16 08:39:49 AM
#4101   Pluristem and Sosei CVC to establish a new midastouch017 12/20/16 08:46:52 AM
#4100   Pluristem and Sosei CVC to Establish a New midastouch017 12/20/16 08:00:54 AM
#4099   United States Congress Passes Bill that Represents a midastouch017 12/13/16 08:02:33 AM
#4098   Things are Heating up... It feels different here- Melon4head 12/08/16 03:55:01 PM
#4097   Pluristem’s PLX-R18 Advances into Second Cohort of Dose midastouch017 12/06/16 07:43:11 AM
#4096   Pluristem Reports First Quarter Fiscal 2017 Corporate and midastouch017 11/15/16 08:41:12 AM
#4095   Pluristem’s $30 Million Equity Funding Approved by Innovative midastouch017 11/10/16 08:25:21 AM
#4094   Pluristem Continues to Strengthen its Position in China midastouch017 11/07/16 08:55:58 AM
#4093   Why Pluristem Therapeutics Inc. Is So Undervalued – midastouch017 11/03/16 02:51:17 PM
#4092   Why Pluristem Therapeutics Is So Undervalued – The trendmkr 11/03/16 02:37:23 PM
#4091   Same in Japan...witness Astellas TO OCATA earlier this north40000 10/28/16 02:27:54 PM
#4090   google this regenerative medicine boom time, its about thesaud 10/28/16 09:13:14 AM
#4089   Pluristem Signs Term Sheet for $30 Million Equity midastouch017 10/25/16 08:12:02 AM
#4088   Pluristem CEO Zami Aberman Re-Elected to Alliance for midastouch017 10/13/16 08:14:45 AM
#4087   when are we going to break out of thesaud 09/26/16 09:22:01 AM
#4086   Pluristem Therapeutics, Inc. - "Biotech Nation" midastouch017 09/22/16 09:48:57 AM
#4085   Pluristem Therapeutics Gears Up For Critical Blood Stem trendmkr 09/19/16 01:15:17 PM
#4084   Pluristem Therapeutics Inc. (PSTI) Gears Up For Critical midastouch017 09/19/16 12:47:16 PM
#4083   its only a phase 1 trial but just thesaud 09/14/16 06:31:48 PM
#4082   Pluristem Advances Towards U.S. Clinical Trial in PLX-R18 midastouch017 09/14/16 08:01:45 AM
#4081   I think it's only a matter of time herbster 09/12/16 12:39:06 PM